• Clinical Management Workshop Series

    The Decision Group organizes with The Decision Institute a series of Clinical Management workshops on the latest academic insights.
    Please click here for the brochure, or go to the dedicated website on the workshop series.

    Continue reading
  • Astra Zeneca and Antonius Conference on Cardio and Outcomes

    Outcome Measures in Cardiology

    Friday the 23rd of September St. Antonius hospital and AstraZeneca organized a successful conference on innovation and outcomes in cardiology. The speakers focused on the status and developments on healthcare quality measurement and reporting from the perspective of health insurers (Ms. D. Monissen, De Friesland), hospitals (Ir. D. M. Schraven, St. Antonius hospital), and cardiologists (prof. S.K. James, MD, PhD). Prof. dr. Fred van Eenennaam started off the conference with a presentation on the methodology and implementation of outcome measures in hospital care. Focus of his presentation are the newest insight and developments of The Decision Group from research and cooperation in their international network with The George Washington University, St. Gallen Universitat, and Harvard Business School. The conference showed a high-level of interaction between cardiologists, hospital executives, patient representatives and government policy makers.

    Please feel free to contact us personally to discuss this topic and the possible opportunities for your organization.

    ir. Maarten Koomans
    dr.
    Paul van der Nat
    prof. dr. Fred van Eenennaam

    Continue reading
  • NVVH publishes quality indicators

    Achmea interested in indicators for new set of medical conditions

    The Dutch Association of Surgery (Dutch: NVVH) today publishes for the second time this year a list of quality indicators. The publication concerns a new set of medical conditions, among which are lung cancer and pancreatic cancer. Health insurer Achmea responds positively and investigates how they can use this for their healthcare procurement, NOS reported this morning.

    From quality indicators to Outcome Measures

    The NVVH is one of the leading medical associations in The Netherlands contributing to the development of quality indicators. The published quality indicators are all process and structure measures, which can be used as minimum requirements for high complexity operations. To get a real insight in the quality of care delivery, outcome measures are an essential ingredient. The NVVH also plays an important role in the development of outcome measures, as they have taken the initiative to develop a national registration of outcomes for medical conditions in surgery.

    Please feel free to contact us personally to discuss this topic and the possible opportunities for your organization.

    ir. Maarten Koomans
    dr.
    Paul van der Nat
    prof. dr. Fred van Eenennaam

    Continue reading
  • Symposium on Outcomes in Cardiology

    The Decision Group on Outcome Measures

    On September 23rd, Antonius hospital and AstraZeneca organize a symposium on innovation, quality and outcomes in cardiology. Partner of The Decision Group, Prof. dr. Fred van Eenennaam presents the latest insights on Outcome Measures.

    Nieuwegein conferentie:Innovatie,kwaliteit en outcomes in cardiologie. 23 september 2011 from algemeen on Vimeo.

    Program in short

    As first speaker, Prof. Fred van Eenennaam will start of the conference with a presentation on outcome measures. The program will end with a promising discussion between Fred and Diana Monissen (CEO De Friesland), Dirk Schraven (board Antonius hospital), and Prof. James Upsalla. Ab Klink, the former Minister of Health Welfare and Sports will open the discussion with his challenging vision for the Dutch healthcare system.

    Invitation.

    On the embedded video above, you will find a complete overview of the program, including an invitation by Dr. J.M. ten Berg. You can apply for registration online at: https://www.benecke.nl/.
    For more information on Outcome Measures and what The Decision Group can do for your organization, do not hesitate to send an e-mail to partner  ir. Maarten Koomans, or prof. dr. Fred van Eenennaam, or call us at +31 (0)346 574 942

    Continue reading
  • Medicare data show gap in hospital performance, perception

    From our international work on outcome measures, we would like to bring your attention to this (click to read the full article)  interesting study by USA today of Medicare data:

    The focus on relevant outcome measures is a key part of improving health care delivery (see also Quality-based selection of hospitals for Transcatheter Heart Valve Interventions and the symposium we organized about the results of this study ). Process measures, structure measures, different types of cost measures, quality measures, medically relevant patient outcome measures, patient reported outcome measures, health economic measures and patient perception and satisfaction measures have all been  intertwined. This strongly obscures effective decision making in healthcare. In our work and with the collaborations with Prof Porter (Outcome Measures project ) and others the opion is that medically relevant patient outcomes should be the yard stick for decision making.

    Whether patient perception and satisfaction measures (client measures) can be used as valid  indicators to get insight in the quality of health outcomes has been debated for some time now. The study of the Medicare data suggests at least to take extreme care in assuming a relationship.

    Please feel free to contact us personally to discuss this topic and the possible opportunities for your organization.

    ir. Maarten Koomans
    dr.
    Paul van der Nat
    prof. dr. Fred van Eenennaam

    Continue reading
  • The Decision Group study on Future value of diagnostics

    Value of diagnostics in healthcare

    In healthcare systems stakeholders have always focused less on diagnostics than on treatments. In current unsustainable healthcare systems however, stakeholders see diagnostics as an important lever to increase the value per Euro spent. Diagnostics influence as much as 60-70% of healthcare decision making while expenditure on diagnostics is even less than 4% of total health expenditure. Before diagnostics can contribute to a productivity and sustainability increase in healthcare however, stakeholders have to gain insight in the non-monetary value of diagnostics.

    The Decision Group study

    For this reason The Decision Group initiated a study on diagnostics. The study resulted in insight in the added value of diagnostics in healthcare and the increased ability to make reliable investment-decisions on diagnostics. The development of validated model for value assessment is aimed to be completed mid-summer of 2011.

    On the picture the executive session we held at Slot Zeist to involve expert opinions in the program.

    Continue reading
  • The Decision Group starts development of Prosensa Case

    Case on the succes of a Dutch biotech company

    The Decision Group has initiated a research project on the Dutch biotech company Prosensa (www.prosensa.nl) and conducts the research with a consortium of partners.
    The research was initiated because of an international academic need for a Harvard style case on relevant and recent strategic topics that biotech companies face. In addition there is a need in The Netherlands to show a success story within the cluster, while Dutch pharma and biotech are facing tough times. Important aspects are the Public-private partnerships, academic institutions and increased focus on the valorization of knowledge.

    Objective

    The objective of the case is to demonstrate, with a thorough and academic Harvard style case, a success story of the Dutch biotech cluster which can be used for (international) teaching at various universities and for promotional activities within the Netherlands or abroad.

    Continue reading
  • Dutch Lifesciences Outlook bron voor publicatie over sector

    FD publication on Medical Life Sciences Sector

    The Dutch Life Science Outlook 2011, which was developed by The Decision Group commissioned by The Life Sciences & Healthcare, was the source for data below publication of the FD on the Dutch Life Sciences sector. Click on the image to the full article (Dutch).

    Continue reading
  • The Decision Group presents the Dutch Life Sciences Outlook 2011

    The Decision Group presents the Dutch Life Sciences Outlook 2011

    Thursday March 10th The Decision Group and LSH presented the Dutch Life Sciences Outlook 2011.
    FD and Trouw resported the launch and present the Outlook in a nutshell. You can click the images to see it in full size
    The websites Medical Facts and FD Selections also published articles on the Outlook 2011.

    You can download a copy of the Life Sciences Outlook 2011 on the LSH website

    [caption id="attachment_406" align="alignleft" width="300" caption="Click picture to enlarge"]OutlookFD[/caption] [caption id="attachment_407" align="alignleft" width="300" caption="Click picture to enlarge"]OutlookTrouw[/caption]

    Continue reading
  • Who are we ?

    Continue reading